As monkeypox cases spread, a key question for public health officials is: who is getting the vaccine? A new report describes the demographics of people in the United States who have received the JYNNEOS vaccine, which is approved to prevent monkeypox. This snapshot helps track who is seeking protection during the outbreak.
The report does not tell us anything about how well the vaccine is working to prevent infection, nor does it share any information about side effects people might have experienced. It is simply a look at who has been vaccinated so far.
Because the report doesn't include findings on vaccine effectiveness or safety, we don't yet know how protective the shots are in this real-world setting. This kind of demographic information is a first step, providing a foundation for future studies that will need to answer those critical questions about protection.
